Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
Tusamitamab ravtansine demonstrated a favorable safety profile, objective responses, and antitumor activity in patients with high CEACAM5-expressing NSq NSCLC.
Authors
- Nathalie Fagniez (ORCID: https://orcid.org/0009-0006-7381-8657)
- María Vieito (ORCID: https://orcid.org/0000-0001-7531-343X)
- Víctor Moreno (ORCID: https://orcid.org/0000-0001-6099-4236)
- Carole Hélissey (ORCID: https://orcid.org/0000-0002-7774-349X)
- Charles Ricordel (ORCID: https://orcid.org/0000-0001-6160-2732)
- Christine Soufflet (ORCID: https://orcid.org/0009-0004-7120-5756)
- Anas Gazzah (ORCID: https://orcid.org/0000-0002-6866-6787)
- Mustapha Chadjaa (ORCID: https://orcid.org/0009-0009-1376-8872)
- François Ghiringhelli (ORCID: https://orcid.org/0000-0002-5465-8305)
- Luis Paz‐Ares (ORCID: https://orcid.org/0000-0002-1947-3364)
- Emiliano Calvo (ORCID: https://orcid.org/0000-0003-4921-829X)
- Nina Masson (ORCID: https://orcid.org/0009-0001-6665-6032)
- Byoung Chul Cho (ORCID: https://orcid.org/0000-0002-5562-270X)
- Fabrice Barlési (ORCID: https://orcid.org/0000-0001-5793-3539)
- Jin-Soo Kim (ORCID: https://orcid.org/0000-0003-2393-5346)
- Sophie Cousin (ORCID: https://orcid.org/0000-0002-4847-6329)
- Dong-Wan Kim
- Anne-Laure Bauchet
- Antoine Italiano
Institutions
- Seoul National University (KR)
- Université de Bordeaux (FR)
- Yonsei University (KR)
- Université Paris-Saclay (FR)
- Institut Gustave Roussy (FR)
- Seoul National University Hospital (KR)
- Sanofi (France) (FR)
- Centre Georges François Leclerc (FR)
- SNUH SMG-SNU Boramae Medical Center (KR)
- Vall d'Hebron Hospital Universitari (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Institut Bergonié (FR)
- Vall d'Hebron Institute of Oncology (ES)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1016/j.jtocrr.2025.100844
- Citations
- 3
- Primary Topic
- Radiopharmaceutical Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 4.08